EMA Approves AI-Powered Lung Nodule Diagnostic Tool with 92% Sensitivity

 The European Medicines Agency (EMA) has granted CE IVDR certification to Qure.ai’s qXR 5.0, an AI medical imaging tool for lung nodule detection. Powered by a quantum-enhanced convolutional neural network, the system achieves 92% clinical sensitivity—exceeding FDA 510(k) requirements—by analyzing chest CT scans in under 15 seconds. It generates interpretable reports linking nodules to clinical guidelines and integrates with hospital PACS systems. Qure.ai notes the tool has reduced diagnostic time for rare lung conditions from 41 days to 3.6 hours in pilot studies with EU hospitals.